An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma

Published:2017-10-26 Issue:4 Volume:5 Page:38
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Stark Felicity,Weeratna Risini,Deschatelets Lise,Gurnani Komal,Dudani Renu,McCluskie Michael,Krishnan Lakshmi

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Link

http://www.mdpi.com/2076-393X/5/4/38/pdf

Reference58 articles.

1. Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review

2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

3. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

4. Final Version of 2009 AJCC Melanoma Staging and Classification

5. Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ether lipids from archaeas in nano-drug delivery and vaccination;International Journal of Pharmaceutics;2023-03

2. Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier;Cancer Cell International;2022-01-03

3. Bifunctional lipids in tumor vaccines: An outstanding delivery carrier and promising immune stimulator;International Journal of Pharmaceutics;2021-10

4. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts;Cell Reports;2021-07

5. Optimal timing of PD-1 blockade in combination with oncolytic virus therapy;Seminars in Cancer Biology;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3